Simpirica Spine was founded in 2006 to develop minimally invasive, flexion-restricting stabilization devices for the spine. The company’s lead product, the LimiFlex Spinal Stabilization System, is designed to address flexion (forward bending) pain and instability without the need for spinal fusion. LimiFlex is CE marked and available in markets outside of the United States, where it typically is used in conjunction with a surgical decompression for the treatment of lumbar spinal stenosis with or without degenerative spondylolisthesis. The LimiFlex Device provides spinal stabilization for patients who could benefit from additional stabilization in flexion. Simpirica Spine developed and tested its technology over a period of many years with the help of clinical and biomechanical experts from around the world. Simpirica Spine recently received approval from the U.S. Food and Drug Administration (FDA) to begin an investigational device exemption (IDE) pivotal clinical study.